Literature DB >> 15151167

Effect of zobo drink (Hibiscus sabdariffa water extract) on the pharmacokinetics of acetaminophen in human volunteers.

J A Kolawole1, A Maduenyi.   

Abstract

Acetaminophen, a common antipyretic-analgesic OTC drug is often administered orally anytime of the day with water or beverages irrespective of possible interactions. Zobo drink, is a sweetened water extract of the dried calyx of Hibiscus Sabdariffa. This work is designed to investigate the effect of zobo drink on an oral dose of acetaminophen. Six healthy male volunteers, ages 28.50 +/- 1.76 years, weighing 62.67 +/- 1.67kg participated in the study. The study was carried out in two phases. In the first phases an oral dose of acetaminophen (1g) was administered to the volunteers and in the second phases, zobo drink was ingested by the volunteers 1.30 h prior the administration of acetaminophen (1g). Acetaminophen concentration in plasma was determined using a validated spectrophotometric method. Pharmacokinetic values obtained were found to be in similar ranges as those previously reported. The absorption parameters t1/2a, Ka, Tmax, Cmax and AUC0-alpha showed no statistically significant changes (p>0.05) after the administration of zobo. There were however statistically significant changes (p<0.05) in Kbeta and t1/2beta of acetaminophen when administered after the zobo drink. This also resulted in 11.69% increase in ClT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151167     DOI: 10.1007/BF03190570

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

Review 1.  The influence of food on the absorption and metabolism of drugs: an update.

Authors:  L Williams; D P Hill; J A Davis; D T Lowenthal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

Review 2.  Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.

Authors:  S B Lippman; K Nash
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

3.  Cheese, wine, and isoniazid.

Authors:  M Toutoungi; R L Carroll; J F Enrico; L Perey
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

4.  Letter: paracetamol measurement.

Authors:  J P Glynn; S E Kendal
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

5.  Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.

Authors:  S Malhotra; D G Bailey; M F Paine; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2001-01       Impact factor: 6.875

Review 6.  Drug interactions with grapefruit juice.

Authors:  B Ameer; R A Weintraub
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

  6 in total
  5 in total

Review 1.  Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.

Authors:  Allison L Hopkins; Marnie G Lamm; Janet L Funk; Cheryl Ritenbaugh
Journal:  Fitoterapia       Date:  2013-01-17       Impact factor: 2.882

2.  Effect of Nigerian meals on the pharmacokinetics of chlorpropamide in type II diabetic patients.

Authors:  M T Bakare-Odunola; A Mustapha; I Abdu Aguye
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jan-Mar       Impact factor: 2.441

3.  In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms.

Authors:  Showande Segun Johnson; Fakeye Titilayo Oyelola; Tolonen Ari; Hokkanen Juho
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

4.  Trace metal toxicity in some food items in three major markets in Ado-Odo/Ota LGA, Ogun State, Nigeria and associated health implications.

Authors:  Opeyemi Isaac Ayanda; Oluwakemi Adetutu Bello; Oluwatosin Ifeanyichukwu Nwabuisi
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

Review 5.  Physiological Effects and Human Health Benefits of Hibiscus sabdariffa: A Review of Clinical Trials.

Authors:  Efigenia Montalvo-González; Zuamí Villagrán; Sughey González-Torres; Laura Elena Iñiguez-Muñoz; Mario Alberto Isiordia-Espinoza; José Martín Ruvalcaba-Gómez; Ramón Ignacio Arteaga-Garibay; José Luis Acosta; Napoleón González-Silva; Luis Miguel Anaya-Esparza
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.